ArticleChina CDC weekly2025
Burden of Musculoskeletal Disorders - Global and BRICS+ Nations, 1990-2021.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Impact of Population Aging on Ergonomic-Related Low Back Pain Across Regions with Different Development Levels.Journal of pain research · 2026Article
- Rehabilitation for People with Inflammatory Arthritis: Meeting the Challenges of a Changing Healthcare Landscape.Journal of clinical medicine · 2025Article
- Global assessment of pain care quality for musculoskeletal disorders: Insights from the quality of care index (QCI) from 1990 to 2021.PloS one · 2025Article
- Time trends in colorectal cancer incidence across the BRICS: an age-period-cohort analysis for the GBD 2021.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Musculoskeletal (MSK) disorders are escalating in the BRICS+ nations. The BRICS+ countries include five primary members of Brazil, Russia, India, China, and South Africa, and five new members of Saudi Arabia, Egypt, the United Arab Emirates (UAE), Iran, and Ethiopia by January 1st, 2024. Methods: Utilizing the Global Burden of Disease (GBD) 2021 database, the study measured MSK disorders burden through incidence, prevalence, and disability-adjusted life years (DALYs), segmented by location, sex, and disease type. The average annual percentage change (AAPC) from 1990 to 2021 was evaluated to track the burden changes. Results: In 2021, among BRICS+ nations, Brazil (2,267) and China (1,616) presented the highest and lowest age-standardized DALYs of MSK disorders per 100,000, respectively. Females had higher DALYs than males. The largest decrease and increase in age-standardized DALYs from 1990 to 2021 occurred in China (-2.35%) and Saudi Arabia (10.74%), respectively. Among all MSK disorders in 2021, low back pain (LBP) was the leading cause of the DALYs, while gout was the least contributor in BRICS+ nations. For males, the DALYs due to LBP, rheumatoid arthritis (RA), osteoarthritis (OA), neck pain (NP), and other MSK disorders except gout were lower than those for females. From 1990 to 2021, age-standardized DALYs of MSK disorders exhibited a significant decreasing trend in China [AAPC=-0.34; 95% confidence interval ( Conclusions: MSK disorders imposed a substantial burden on BRICS+ countries, particularly in Brazil and Iran, with distinct patterns requiring tailored healthcare policies and resource distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.